Gene · 23175
Papers1,577
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,577
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring lipin1 as a promising therapeutic target for the treatment of Duchenne muscular dystrophy. | J Transl Med | 2024 | 39014470 | PubTator, text mining | PubMed |
| Hepatoprotective effects and mechanisms of l-theanine and epigallocatechin gallate combined intervention in alcoholic fatty liver rats. | J Sci Food Agric | 2024 | 38873964 | PubTator, text mining | PubMed |
| Alternative isoform expression of key thermogenic genes in human beige adipocytes. | Front Endocrinol (Lausanne) | 2024 | 38859907 | PubTator, text mining | PubMed |
| Mechanistic exploration of the shenlian formula in the suppression of atherosclerosis progression via network pharmacology and in vivo experimental validation. | J Ethnopharmacol | 2024 | 38801914 | PubTator, text mining | PubMed |
| Differential reliance of CTD-nuclear envelope phosphatase 1 on its regulatory subunit in ER lipid synthesis and storage. | Mol Biol Cell | 2024 | 38776127 | PubTator, text mining | PubMed |
| Bronchopulmonary dysplasia: analysis and validation of ferroptosis-related diagnostic biomarkers and immune cell infiltration features. | Pediatr Res | 2024 | 38760473 | PubTator, text mining | PubMed |
| Intermittent glucocorticoid treatment improves muscle metabolism via the PGC1α/Lipin1 axis in an aging-related sarcopenia model. | J Clin Invest | 2024 | 38702076 | PubTator, text mining | PubMed |
| Validation of mitochondrial biomarkers and immune dynamics in polycystic ovary syndrome. | Am J Reprod Immunol | 2024 | 38661639 | PubTator, text mining | PubMed |
| Nuclear lipid droplets in Caco2 cells originate from nascent precursors and in situ at the nuclear envelope. | J Lipid Res | 2024 | 38570093 | PubTator, text mining | PubMed |
| Regulation of the Nur77-P2X7r Signaling Pathway by Nodakenin: A Potential Protective Function against Alcoholic Liver Disease. | Molecules | 2024 | 38474588 | PubTator, text mining | PubMed |
| Therapeutic potential of lipin inhibitors for the treatment of cancer. | Biochem Pharmacol | 2024 | 38442792 | PubTator, text mining | PubMed |
| Dysregulation of ferroptosis-related genes in granulosa cells associates with impaired oocyte quality in polycystic ovary syndrome. | Front Endocrinol (Lausanne) | 2024 | 38390208 | PubTator, text mining | PubMed |
| Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies. | Chin Med | 2024 | 38310315 | PubTator, text mining | PubMed |
| LncRNA SOX9-AS1 triggers a transcriptional program involved in lipid metabolic reprogramming, cell migration and invasion in triple-negative breast cancer. | Sci Rep | 2024 | 38233470 | PubTator, text mining | PubMed |
| Low-dose Olaparib improves septic cardiac function by reducing ferroptosis via accelerated mitophagy flux. | Pharmacol Res | 2024 | 38228256 | PubTator, text mining | PubMed |
| Fatty acid synthesis suppresses dietary polyunsaturated fatty acid use. | Nat Commun | 2024 | 38167725 | PubTator, text mining | PubMed |
| The Saccharomyces cerevisiae Spo7 basic tail is required for Nem1-Spo7/Pah1 phosphatase cascade function in lipid synthesis. | J Biol Chem | 2024 | 38141768 | PubTator, text mining | PubMed |
| Circular RNAs in non-alcoholic fatty liver disease: Functions and clinical significance. | RNA Biol | 2024 | 38113132 | PubTator, text mining | PubMed |
| Phosphatidate phosphatase Lipin1 involves in diabetic encephalopathy pathogenesis via regulating synaptic mitochondrial dynamics. | Redox Biol | 2024 | 38103341 | PubTator, text mining | PubMed |
| Catalytic core function of yeast Pah1 phosphatidate phosphatase reveals structural insight into its membrane localization and activity control. | J Biol Chem | 2024 | 38097185 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23175/papers?page=5